Renal Division Department of Medicine Peking University First Hospital Institute of Nephrology Peking University Beijing China.
Key Laboratory of Renal Disease National Health and Family Planning Commission of the People's Republic of China Key Laboratory of Chronic Kidney Disease Prevention and Treatment Ministry of Education Beijing China.
J Am Heart Assoc. 2020 Jun 16;9(12):e015359. doi: 10.1161/JAHA.120.015359. Epub 2020 Jun 6.
Background It is unclear whether short-term blood pressure variability is associated with renal outcomes in patients with chronic kidney disease. Methods and Results This study analyzed data from participants in the C-STRIDE (Chinese Cohort Study of Chronic Kidney Disease) who had chronic kidney disease stages 1 to 4. Short-term blood pressure variability was measured by calculating the weighted SD (w-SD) of systolic blood pressure (SBP). Renal outcomes were defined as dialysis initiation and/or transplantation. Risk factors associated with w-SD of SBP were evaluated by linear regression. Associations of short-term SBP variability with renal outcomes were evaluated by Cox regression. In total, 1421 patients with chronic kidney disease were included in this study (mean age, 49.4±13.6 years; 56.2% men; estimated glomerular filtration rate, 50.5±29.3 mL/min per 1.73 m; proteinuria, 0.9 [0.3-2.0] g/d). Mean w-SD of SBP was 12.6±4.4 mm Hg. w-SD of SBP was independently associated with older age, 24-hour SBP, blood pressure circadian pattern, and angiotensin II receptor blocker treatment. During a median follow-up of 4.9 years, 237 patients developed renal outcomes (37.01 per 1000 patient-years). The incidence rate increased across the quartiles of w-SD (log-rank =0.005). w-SD of SBP was associated with an increased risk of renal outcomes, both as a continuous variable (hazard ratio [HR], 1.47; 95% CI, 1.09-1.99) and as a categorical variable (quartile 4 versus quartile 1: HR, 1.60; 95% CI, 1.08-2.36), independent of 24-hour SBP, daytime SBP, and nighttime SBP. Conclusions Short-term SBP was independently associated with the risk of dialysis initiation and/or transplantation in patients with chronic kidney disease.
背景 目前尚不清楚短期血压变异性与慢性肾脏病患者的肾脏结局是否相关。
方法 本研究分析了 C-STRIDE(中国慢性肾脏病队列研究)参与者的数据,这些参与者患有 1 至 4 期慢性肾脏病。通过计算收缩压(SBP)的加权标准差(w-SD)来测量短期血压变异性。肾脏结局定义为开始透析和/或移植。通过线性回归评估与 SBP 的 w-SD 相关的危险因素。通过 Cox 回归评估短期 SBP 变异性与肾脏结局的相关性。
共纳入 1421 例慢性肾脏病患者(平均年龄 49.4±13.6 岁;56.2%为男性;估计肾小球滤过率为 50.5±29.3ml/min/1.73m;蛋白尿为 0.9[0.3-2.0]g/d)。SBP 的平均 w-SD 为 12.6±4.4mmHg。SBP 的 w-SD 与年龄较大、24 小时 SBP、血压昼夜节律模式和血管紧张素 II 受体阻滞剂治疗独立相关。在中位随访 4.9 年期间,237 例患者发生肾脏结局(37.01/1000 患者年)。w-SD 的四分位间距增加,发生率也随之增加(对数秩检验=0.005)。SBP 的 w-SD 与肾脏结局风险增加相关,无论是作为连续变量(危险比[HR],1.47;95%置信区间[CI],1.09-1.99)还是作为分类变量(四分位 4 与四分位 1:HR,1.60;95%CI,1.08-2.36),独立于 24 小时 SBP、日间 SBP 和夜间 SBP。
结论 短期 SBP 与慢性肾脏病患者开始透析和/或移植的风险独立相关。